Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2025-12-24 @ 1:09 PM
NCT ID:
NCT02482961
Eligibility Criteria:
Inclusion Criteria:
1. All adult patients (aged ≥18 years)
2. Microbiological evidence (sputum, urine, blood) of infection due to carbapenem-resistant Acinetobacter baumannii during hospitalization
3. Intravenous Colistimethate sodium treated patient with Acinetobacter baumannii infection who fulfill the above criteria
4. Patients who agree to the gathering clinical information by means of an informed consent
Exclusion Criteria:
1. Pregnancy and lactating women
2. Patients receiving Colistimethate sodium therapy for \<48 hours
3. Patient of chronic renal disease defined as a Creatinine clearance \<10 mL/min, Or requirement for peritoneal or hemo-dialysis or hemofiltration
4. Known hypersensitivity to Colistimethate sodium
5. Receiving intravenous colistin therapy within the past 30 days
6. Patients treated with nebulized Colistimethate sodium
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02482961
Study Brief:
Protocol Section:
NCT02482961